LongevityCompanion animal
Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates: implications for senolytic clinical trial design
Ross JL, Bilkei-Gorzo A, Brzezicka A, et al. · GeroScience · 2023
PMID: 37261678 · DOI: 10.1007/s11357-023-00830-5
Summary
Preclinical nonhuman primate trial of long-term intermittent dasatinib + quercetin senolytic regimen. Endpoints: senescence markers, systemic inflammation, functional aging outcomes over the dosing window.
Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.
More Longevity citations
- Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR miceBiogerontology · 2003
- Effect of epitalon and melatonin on life span and spontaneous carcinogenesis in senescence accelerated mice (SAM)Vopr Onkol · 2005
- Peptides and AgeingNeuro Endocrinol Lett · 2002